The trajectory of U.S. interest rates and corporate valuations remains the dominant driver of acquisition probabilities before 2027, with Federal Reserve policy communications and Treasury yields directly influencing financing costs and deal economics. Strong corporate balance sheets and elevated cash reserves in technology, healthcare, and consumer sectors continue to support strategic M&A, while antitrust enforcement and regulatory timelines introduce execution risk for larger transactions. Recent equity market levels provide acquisition currency for stock-based deals, though volatility measures such as the VIX can shift risk appetite quickly. Key upcoming catalysts include FOMC meetings, quarterly earnings releases, and any new guidance on capital deployment from major industry players, all of which feed into trader consensus reflected in market-implied odds.